Overactive Bladder Treatment Market: Global Market Synopsis, Growth Factors, Industry Segmentation, Regional Analysis And Competitive Analysis 2025
According to a new report published by Reports Monitor titled, “Overactive bladder treatment market by type, by treatment, by route of administration and by end user: Global Opportunity Analysis and Industry Forecast, 2017–2025,” the overactive bladder treatment market was valued at XX million in 2016, and is projected to reach at XX million by 2025, growing at a CAGR of XX% from 2017 to 2025. North America dominates the overactive bladder treatment market, in terms of value, and is expected to maintain this trend throughout the forecast period.
Overactive bladder is a medical condition which is characterized by sudden and frequent incidence of urination that patient cannot control which is often observe in geriatric population.
Increasing geriatric population led to the incidence of the overactive bladder which propels the growth of the market.
Research and development of gene therapy and pharmacogenomics drugs for the treatment of the overactive bladder condition creates opportunity for the market.
According to the official foundation of the American urology association 30% of men and 40% of women in America are suffering from the overactive bladder symptoms and this number is keep on increasing which creates huge market in north America.
Availability of generic drugs increases the consumption in developing economies this can boost the growth of the market
Undesired systemic outcome of current treatment and lack of awareness can hamper the growth of the market.
• Anticholinergics Segment is expected to be widely used drug class as it is first line of treatment in overactive bladder condition.
• High incidence of the idiopathic bladder overactivity is major contributor to the market.
• According to official foundation of the America 30% of men and 40% of women are suffering from the symptoms of overactive bladder this makes north America potential region for this market.
The major companies profiled in the report include Astellas Pharma, Inc., Pfizer, Inc., Allergan, Plc., Teva Pharmaceutical Industries Limited, Mylan N.V., Medtronic plc, Endo International plc., Sanofi, Hisamitsu Pharmaceutical Co., Inc., Aurobindo Pharma Limited, Apotex Inc. and Cogentix Medical, Inc.
About Garner Insights:
We at Garner Insights.com provide a comprehensive analysis by providing in-depth reports of the various market verticals. Our Mission is to provide a detailed analysis of the vast markets worldwide backed by rich data. Decision makers can now rely on our well-defined data gathering methods to get the correct and accurate market forecasting along with detailed analysis.